Syneos Health (NASDAQ:SYNH) Price Target Cut to $37.00 by Analysts at Barclays

Syneos Health (NASDAQ:SYNH – Get Rating) had its price target cut by research analysts at Barclays from $45.00 to $37.00 in a note issued to investors on Tuesday, The Fly reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 5.93% from the company’s previous […]

Related Keywords

Massachusetts ,United States ,Robertw Baird , ,Jpmorgan Chase Co ,Vanguard Group Inc ,Clinical Solutions ,Clearbridge Investments ,Analyst Recommendations For Syneos Health ,News Ratings For Syneos Health Daily ,Massachusetts Financial Services Co ,Hedge Funds Weigh In On Syneos Health ,Syneos Health Trading ,Barclays ,Syneos Health Inc ,Syneos Health ,Get Rating ,Financial Services ,State Street Corp ,Street Corp ,Commercial Solutions ,Syneos Health Daily ,Nasdaq Synh ,Synh ,Medical ,Lower Price Target ,Barclays Plc ,